Safety of discontinuing co-trimoxazole prophylaxis among Ugandan adults on antiretroviral therapy (ART)

Category Primary study
Registry of TrialsISRCTN registry
Year 2010
Stopping concurrent prophylactic treatment with co-trimoxazole in adult Ugandan patients on antiretroviral therapy, will not lead to an excess of clinical events (predefined co-trimoxazole preventable clinical events) or death, but will lead to a significant reduction in the incidence of grade 3 or 4 haematological adverse events of antiretroviral therapy (ART).
Epistemonikos ID: c4504cc738ce719f3d2f37b0acd9789721a824c8
First added on: Mar 20, 2020